Oct 02, 2018 (Heraldkeeper via COMTEX) -- Global Asthma Inhaler Device Market – Industry Updates
Feb 2017 BI received expantion of FDA approval of the use of Tiotropium Respimat for treatment of Asthma in Children.
Nov 2016 Chiesi acquires Atopix therapeutics.
Feb 2015 AstraZeneca and Actavis Plc have entered into a definitive agreement under which AstraZeneca will acquire the rights to Actavis' branded respiratory business in the U.S. and Canada for an initial consideration of $600 million on completion and low single-digit royalties above certain revenue threshold.
The inflammation results in the temporary narrowing of the airways carrying oxygen to the lungs.
This causes asthmatic symptoms such as shortness of breath, coughing, wheezing, and chest tightness.
